N/A
Manufactured by Rugby Laboratories
4,296 FDA adverse event reports analyzed
Last updated: 2026-04-15
ALUMINUM HYDROXIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Rugby Laboratories. The most commonly reported adverse reactions for ALUMINUM HYDROXIDE include DRUG INTERACTION, ELECTROCARDIOGRAM QT PROLONGED, DRUG LEVEL INCREASED, SCHIZOAFFECTIVE DISORDER, OFF LABEL USE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ALUMINUM HYDROXIDE.
Out of 704 classified reports for ALUMINUM HYDROXIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 4,296 FDA FAERS reports that mention ALUMINUM HYDROXIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INTERACTION, ELECTROCARDIOGRAM QT PROLONGED, DRUG LEVEL INCREASED, SCHIZOAFFECTIVE DISORDER, OFF LABEL USE, PRODUCT USE ISSUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Rugby Laboratories in connection with ALUMINUM HYDROXIDE. Always verify the specific product and NDC with your pharmacist.